Op dinsdag heeft Bernstein SocGen Group haar standpunt over Pfizer Inc. (NYSE:PFE) aandelen aangepast door het koersdoel te verlagen van $ 32,00 naar $ 30,00, terwijl het Market Perform-advies werd ge ...

Health experts have slammed the FDA as 'corrupt' and 'in bed with Big Pharma' after its former drug chief Dr Patrizia ...

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief ...

In a move that will raise eyebrows in Washington, Pfizer has hired the former director of the FDA's Center for Drug ...

Patrizia Cavazzoni, formerly the top regulator of the drug division of the FDA, will join Pfizer as chief medical officer.

The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...

ADCETRIS, een antilichaam-geneesmiddelconjugaat, richt zich op CD30-positieve tumorcellen en is sinds de eerste goedkeuring ...

Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida ...

Pfizer Inc. has announced that Patrizia Cavazzoni, M.D. will rejoin the company as Chief Medical Officer, Executive Vice ...

After leaving the FDA, where she served as director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., ...

Pfizer appoints Patrizia Cavazzoni as chief medical officer, the U.S. delays the definition of 'healthy' on labels, issues ...

Pfizer yesterday revealed that Dr Patrizia Cavazzoni will rejoin the pharma giant as chief medical officer, executive vice ...